VEGFA and cancer: Cancer cells exploit HSP90’s chaperone function to protect mutated and overexpressed oncoproteins, such as hypoxic inducible factor (HIF) and vascular endothelial growth factor (VEGF), from misfolding and degradation, thereby enhancing cancer cell survival [108].